Lmr Partners LLP Prothena Corp Public LTD CO Transaction History
Lmr Partners LLP
- $10.9 Billion
- Q3 2024
A detailed history of Lmr Partners LLP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Lmr Partners LLP holds 41,500 shares of PRTA stock, worth $672,715. This represents 0.02% of its overall portfolio holdings.
Number of Shares
41,500Holding current value
$672,715% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PRTA
# of Institutions
184Shares Held
42.7MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$188 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$67.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$62.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$62 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$28.2 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $761M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...